Association of coronary artery disease with polymorphisms of angiotensin-converting enzyme and methylenetetrahydrofolate reductase gene

Indian Heart Journal

Volumn 58, Issue 4, 2006, Pages 330-335

  Dalal, Ashwin B ^a   Tewari, Deepshikha ^a   Tewari, Satyendra ^a   Sharma, Mukesh K ^a   Pradhan, Mandakani ^a   Gupta, Usha Rani ^a   Sinha, Nakul ^a   Agarwal, Sarita ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Angiotensin converting enzyme; Coronary artery disease; Methylenetetrahydrofolate reductase; Polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); DIPEPTIDYL CARBOXYPEPTIDASE; HOMOCYSTEINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HYPERTENSION; INDIA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; CORONARY ARTERY DISEASE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; METHYLENETETRAHYDROFOLATE DEHYDROGENASE (NADP); METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 33845427943     PISSN: 00194832     EISSN: 00194832     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Nair KG, Shalia KK, Ashavaid TF, et al. Coronary heart disease, hypertension and angiotensinogen gene variants in Indian population. J Clin Lab Anal 2003;17:141-46
2. Ashavaid TF, Shalia KK, Nair KG, et al. ACE and AT1R gene polymorphisms and hypertension in Indian population. J Clin Lab Anal 2000;14:230-37.
3. Trip MD, Smulders YM, Wegman JJ, et al. Frequent mutation in the ABCC6 gene (R1141X) is associated with a strong increase in prevalence of coronary artery disease. Circulation 2002;106:773-75.
4. Arking DE, Becker DM, Yanek LR, et al. KLOTHO allele status and the risk of early onset occult coronary artery disease. Am J Hum Genet 2003;72:1154-61.
5. Rieder MJ, Taylor SL, Clark AG, et al. Sequence variation in the human angiotensin converting enzyme. Nat Genet 1999;22:59-62
6. Batzer MA, Stoneking M, Alegria-Hartman M, et al. African origin of human specific polymorphic Alu insertions. Proc Natl Acad Sci 1994;91:12888-92.
7. Tiret L, Rigat B, Visvikis S, et al. Evidence from combined segregation and linkage analysis that a variant of the angiotensin I converting enzyme gene controls plasma ACE levels. Am J Hum Genet 1992;51:197-205.
8. Zhu X, McKenzie CA, Forrester T, et al. Localization of a small genomic region associated with elevated ACE. Am J Hum Genet 2000; 67:1144-53.
9. Marian AJ. Genetic markers: genes involved in atherosclerosis. J Cardiovasc Risk 1997;4:383-89.
10. McKenzie CA, Julier C, Forrester T, et al. Segregation and linkage analysis of serum angiotensin I converting enzyme levels: evidence for two quantitative trait loci. Am J Hum Genet 1995;57:1426-35.
11. Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I converting enzyme gene accounting for half the variation of serum enzyme levels. J Clin Invest 1990;86:1343-46.
12. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-44.
13. Samani NJ, Thompson JR, O'Toole L, et al. A meta-analysis of the association of the deletion allele of the angiotensin converting enzyme with myocardial infarction. Circulation 1996; 94:708-12.
14. Zak I, Niemiec P, Sarecka B, et al. Carrier state of D allele in ACE gene insertion/deletion polymorphism is associated with coronary artery disease, in contrast to C677T transition in the MTHFR gene. Acta Biochim Pol 2003;50:527-34.
15. Pasha MA, Khan AP, Kumar R, et al. Variations in angiotensin I converting enzyme gene insertion/deletion polymorphism in Indian populations of different ethnic origins. J Biosci 2002;27:67-70.
16. Lindpaintner K, Pfeffer MA, Kreutz R, et al. A prospective evaluation of an angiotensin converting enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995;332:706-11.
17. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-13.
18. Nair KG, Nair SR, Ashavaid TF, et al. Methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia as a risk factor for coronary heart disease in Indian population. J Assoc Physicians India 2002;50:9-15.
19. Rigat B, Hubert C, Corvol P, et al. PCR detection of the insertion/deletion polymorphism in the human angiotensin converting enzyme gene. Nucleic Acids Res 1992;20:1433.
20. Mastana S, Nunn J. Angiotensin converting enzyme deletion polymorphism is associated with hypertension in a Sikh population. Hum Hered 1997;47:250-53.
21. Agrawal S, Singh VP, Tewari S, et al. Angiotensin converting enzyme gene polymorphism in coronary artery disease in North India. Ind Heart J 2004;56:44-47.
22. Gardemann A, Fink M, Stricker J, et al. ACE I/D gene polymorphism: presence of ACE D allele increases the risk of coronary artery disease in younger individuals. Atherosclerosis 1998;139:153-59.
23. Gulec S, Aras O, Akar E, et al. Methylenetetrahydrofolate reductase gene polymorphism and risk of premature myocardial infarction. Clin Cardiol 2001;24:281-a 4.
24. Brugada R, Marian AJ. A common mutation in methylenetetrahydrofolate reductase is not major risk factor of coronary artery disease or myocardial infarction. Atherosclerosis 1997;128:107-12.